SK281135B6 - Derivát arylbenzoylguanidínu, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje - Google Patents
Derivát arylbenzoylguanidínu, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje Download PDFInfo
- Publication number
- SK281135B6 SK281135B6 SK1053-95A SK105395A SK281135B6 SK 281135 B6 SK281135 B6 SK 281135B6 SK 105395 A SK105395 A SK 105395A SK 281135 B6 SK281135 B6 SK 281135B6
- Authority
- SK
- Slovakia
- Prior art keywords
- diaminomethylene
- methylphenyl
- formula
- methyl
- acid
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title claims abstract description 9
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract description 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 62
- 150000003839 salts Chemical class 0.000 claims abstract description 18
- 206010003119 arrhythmia Diseases 0.000 claims abstract description 6
- 230000006793 arrhythmia Effects 0.000 claims abstract description 6
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims description 35
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 28
- 239000002253 acid Substances 0.000 claims description 15
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims description 14
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims description 14
- 238000011282 treatment Methods 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 206010002383 Angina Pectoris Diseases 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- AJDQRQQNNLZLPM-UHFFFAOYSA-N n-(diaminomethylidene)benzamide Chemical compound NC(N)=NC(=O)C1=CC=CC=C1 AJDQRQQNNLZLPM-UHFFFAOYSA-N 0.000 claims description 4
- 206010061216 Infarction Diseases 0.000 claims description 3
- 230000007574 infarction Effects 0.000 claims description 3
- 230000003449 preventive effect Effects 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 239000003638 chemical reducing agent Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 125000004981 cycloalkylmethyl group Chemical group 0.000 claims description 2
- FJOOYRCQANEWMT-UHFFFAOYSA-N n-(diaminomethylidene)-2-ethyl-3-methylsulfonyl-4-phenylbenzamide Chemical compound CCC1=C(C(=O)N=C(N)N)C=CC(C=2C=CC=CC=2)=C1S(C)(=O)=O FJOOYRCQANEWMT-UHFFFAOYSA-N 0.000 claims description 2
- XQYPJPSITWOGIY-UHFFFAOYSA-N n-(diaminomethylidene)-2-methyl-4-(4-methylphenyl)-5-methylsulfonylbenzamide Chemical compound C1=CC(C)=CC=C1C1=CC(C)=C(C(=O)N=C(N)N)C=C1S(C)(=O)=O XQYPJPSITWOGIY-UHFFFAOYSA-N 0.000 claims description 2
- 125000001624 naphthyl group Chemical group 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 2
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 claims 1
- JNCMHMUGTWEVOZ-UHFFFAOYSA-N F[CH]F Chemical compound F[CH]F JNCMHMUGTWEVOZ-UHFFFAOYSA-N 0.000 claims 1
- 108010081348 HRT1 protein Hairy Proteins 0.000 claims 1
- 102100021881 Hairy/enhancer-of-split related with YRPW motif protein 1 Human genes 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- RCKAWQCNULZGJE-UHFFFAOYSA-N n-(diaminomethylidene)-2-ethyl-4-(4-methylphenyl)-5-methylsulfonylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(CC)=CC(C=2C=CC(C)=CC=2)=C1S(C)(=O)=O RCKAWQCNULZGJE-UHFFFAOYSA-N 0.000 claims 1
- ZGLHRRNQPNKIHQ-UHFFFAOYSA-N n-(diaminomethylidene)-2-ethyl-5-methylsulfonyl-4-naphthalen-2-ylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(CC)=CC(C=2C=C3C=CC=CC3=CC=2)=C1S(C)(=O)=O ZGLHRRNQPNKIHQ-UHFFFAOYSA-N 0.000 claims 1
- GGSMVRMJSSOOLO-UHFFFAOYSA-N n-(diaminomethylidene)-2-methyl-5-methylsulfonyl-4-(4-phenylphenyl)benzamide Chemical compound C1=C(C(=O)N=C(N)N)C(C)=CC(C=2C=CC(=CC=2)C=2C=CC=CC=2)=C1S(C)(=O)=O GGSMVRMJSSOOLO-UHFFFAOYSA-N 0.000 claims 1
- 125000005004 perfluoroethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 claims 1
- 102000003669 Antiporters Human genes 0.000 abstract description 2
- 108090000084 Antiporters Proteins 0.000 abstract description 2
- 239000003416 antiarrhythmic agent Substances 0.000 abstract description 2
- 239000003112 inhibitor Substances 0.000 abstract description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- -1 isopentyl (3-methylbutyl) Chemical group 0.000 description 35
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 29
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 13
- 239000004480 active ingredient Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 125000006239 protecting group Chemical group 0.000 description 11
- 239000002904 solvent Substances 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 239000002585 base Substances 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 6
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 6
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 125000002252 acyl group Chemical group 0.000 description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 206010021143 Hypoxia Diseases 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 4
- 150000001735 carboxylic acids Chemical class 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 238000007327 hydrogenolysis reaction Methods 0.000 description 4
- 239000012442 inert solvent Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- 125000001917 2,4-dinitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1*)[N+]([O-])=O)[N+]([O-])=O 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012154 double-distilled water Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- GOHXXGPPVFVTSB-UHFFFAOYSA-N n-(diaminomethylidene)-5-methylsulfonyl-4-phenyl-2-propan-2-ylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(C(C)C)=CC(C=2C=CC=CC=2)=C1S(C)(=O)=O GOHXXGPPVFVTSB-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- NSJVYHOPHZMZPN-UHFFFAOYSA-N (2-methylphenyl)boronic acid Chemical compound CC1=CC=CC=C1B(O)O NSJVYHOPHZMZPN-UHFFFAOYSA-N 0.000 description 2
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- FSOSNXGSWLKVKY-UHFFFAOYSA-N 2-butan-2-yl-n-(diaminomethylidene)-4-(4-methylphenyl)-5-methylsulfonylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(C(C)CC)=CC(C=2C=CC(C)=CC=2)=C1S(C)(=O)=O FSOSNXGSWLKVKY-UHFFFAOYSA-N 0.000 description 2
- UMXQBRPDIHOPFK-UHFFFAOYSA-N 2-butyl-n-(diaminomethylidene)-4-(4-methylphenyl)-5-methylsulfonylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(CCCC)=CC(C=2C=CC(C)=CC=2)=C1S(C)(=O)=O UMXQBRPDIHOPFK-UHFFFAOYSA-N 0.000 description 2
- GWYYOHIUQNXJQB-UHFFFAOYSA-N 2-butyl-n-(diaminomethylidene)-5-methylsulfonyl-4-phenylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(CCCC)=CC(C=2C=CC=CC=2)=C1S(C)(=O)=O GWYYOHIUQNXJQB-UHFFFAOYSA-N 0.000 description 2
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 2
- JUXCNQXIDVEUAE-UHFFFAOYSA-N 3-methylsulfonylbenzamide Chemical compound CS(=O)(=O)C1=CC=CC(C(N)=O)=C1 JUXCNQXIDVEUAE-UHFFFAOYSA-N 0.000 description 2
- YNYSKRCZLQPSHY-UHFFFAOYSA-N 4-bromo-n-(diaminomethylidene)-2-methyl-5-methylsulfonylbenzamide Chemical compound CC1=CC(Br)=C(S(C)(=O)=O)C=C1C(=O)N=C(N)N YNYSKRCZLQPSHY-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 230000002337 anti-port Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000001146 hypoxic effect Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- KJXAARWYUOTFMX-UHFFFAOYSA-N methyl 2-ethyl-4-(4-methylphenyl)-5-sulfamoylbenzoate Chemical compound C1=C(C(=O)OC)C(CC)=CC(C=2C=CC(C)=CC=2)=C1S(N)(=O)=O KJXAARWYUOTFMX-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- XGSDORUXQJREMM-UHFFFAOYSA-N n-(diaminomethylidene)-2-(fluoromethyl)-4-(4-methylphenyl)-5-methylsulfonylbenzamide Chemical compound C1=CC(C)=CC=C1C1=CC(CF)=C(C(=O)N=C(N)N)C=C1S(C)(=O)=O XGSDORUXQJREMM-UHFFFAOYSA-N 0.000 description 2
- AGEBPBPHEZDDIJ-UHFFFAOYSA-N n-(diaminomethylidene)-2-ethyl-5-methylsulfonyl-4-phenylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(CC)=CC(C=2C=CC=CC=2)=C1S(C)(=O)=O AGEBPBPHEZDDIJ-UHFFFAOYSA-N 0.000 description 2
- PUCCDQHDTHQEBB-UHFFFAOYSA-N n-(diaminomethylidene)-2-methoxy-4-(4-methylphenyl)-5-methylsulfonylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(OC)=CC(C=2C=CC(C)=CC=2)=C1S(C)(=O)=O PUCCDQHDTHQEBB-UHFFFAOYSA-N 0.000 description 2
- PORUFTOBZZDRJX-UHFFFAOYSA-N n-(diaminomethylidene)-2-methyl-5-methylsulfonyl-4-phenylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(C)=CC(C=2C=CC=CC=2)=C1S(C)(=O)=O PORUFTOBZZDRJX-UHFFFAOYSA-N 0.000 description 2
- OZXNFMWXIJKSIJ-UHFFFAOYSA-N n-(diaminomethylidene)-4-(4-methylphenyl)-5-methylsulfonyl-2-(1,1,2,2,2-pentafluoroethyl)benzamide Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)C(F)(F)F)=C(C(=O)N=C(N)N)C=C1S(C)(=O)=O OZXNFMWXIJKSIJ-UHFFFAOYSA-N 0.000 description 2
- RNBOXEFQBMPVPG-UHFFFAOYSA-N n-(diaminomethylidene)-4-(4-methylphenyl)-5-methylsulfonyl-2-nitrobenzamide Chemical compound C1=CC(C)=CC=C1C1=CC([N+]([O-])=O)=C(C(=O)N=C(N)N)C=C1S(C)(=O)=O RNBOXEFQBMPVPG-UHFFFAOYSA-N 0.000 description 2
- UTZKGCNCCMRQAZ-UHFFFAOYSA-N n-(diaminomethylidene)-4-(4-methylphenyl)-5-methylsulfonyl-2-propan-2-ylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(C(C)C)=CC(C=2C=CC(C)=CC=2)=C1S(C)(=O)=O UTZKGCNCCMRQAZ-UHFFFAOYSA-N 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 238000003797 solvolysis reaction Methods 0.000 description 2
- 150000003460 sulfonic acids Chemical class 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- QNEGDGPAXKYZHZ-UHFFFAOYSA-N (2,4-dichlorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C=C1Cl QNEGDGPAXKYZHZ-UHFFFAOYSA-N 0.000 description 1
- SQTUYFKNCCBFRR-UHFFFAOYSA-N (2,4-dimethoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C(OC)=C1 SQTUYFKNCCBFRR-UHFFFAOYSA-N 0.000 description 1
- TYONHSPZXLFWKI-UHFFFAOYSA-N (2,4-dimethylphenyl)boronic acid Chemical compound CC1=CC=C(B(O)O)C(C)=C1 TYONHSPZXLFWKI-UHFFFAOYSA-N 0.000 description 1
- DKYRKAIKWFHQHM-UHFFFAOYSA-N (3,5-dichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=CC(Cl)=C1 DKYRKAIKWFHQHM-UHFFFAOYSA-N 0.000 description 1
- AFSSVCNPDKKSRR-UHFFFAOYSA-N (3-bromophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(Br)=C1 AFSSVCNPDKKSRR-UHFFFAOYSA-N 0.000 description 1
- BJQCPCFFYBKRLM-UHFFFAOYSA-N (3-methylphenyl)boronic acid Chemical compound CC1=CC=CC(B(O)O)=C1 BJQCPCFFYBKRLM-UHFFFAOYSA-N 0.000 description 1
- VOAAEKKFGLPLLU-UHFFFAOYSA-N (4-methoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C=C1 VOAAEKKFGLPLLU-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- KWCPQPFOPUCWPH-UHFFFAOYSA-N 1-(oxomethylidene)guanidine Chemical group NC(=N)N=C=O KWCPQPFOPUCWPH-UHFFFAOYSA-N 0.000 description 1
- IRNDQZKWHZMXMR-UHFFFAOYSA-N 2-(difluoromethyl)-3-methylsulfonyl-4-phenylbenzoic acid Chemical compound C1=CC(C(O)=O)=C(C(F)F)C(S(=O)(=O)C)=C1C1=CC=CC=C1 IRNDQZKWHZMXMR-UHFFFAOYSA-N 0.000 description 1
- YHRIWMDKOAPYME-UHFFFAOYSA-N 2-(difluoromethyl)-4-phenyl-3-sulfamoylbenzoic acid Chemical compound C1=CC(C(O)=O)=C(C(F)F)C(S(=O)(=O)N)=C1C1=CC=CC=C1 YHRIWMDKOAPYME-UHFFFAOYSA-N 0.000 description 1
- FUIWRFKRCPDKQI-UHFFFAOYSA-N 2-(fluoromethyl)-4-(4-methylphenyl)-3-methylsulfonylbenzoic acid Chemical compound C1=CC(C)=CC=C1C1=CC=C(C(O)=O)C(CF)=C1S(C)(=O)=O FUIWRFKRCPDKQI-UHFFFAOYSA-N 0.000 description 1
- CIWFTKGUDXXMKP-UHFFFAOYSA-N 2-(fluoromethyl)-4-(4-methylphenyl)-3-sulfamoylbenzoic acid Chemical compound C1=CC(C)=CC=C1C1=CC=C(C(O)=O)C(CF)=C1S(N)(=O)=O CIWFTKGUDXXMKP-UHFFFAOYSA-N 0.000 description 1
- OXQGTIUCKGYOAA-UHFFFAOYSA-N 2-Ethylbutanoic acid Chemical compound CCC(CC)C(O)=O OXQGTIUCKGYOAA-UHFFFAOYSA-N 0.000 description 1
- OOYOJUWCHDVXOR-UHFFFAOYSA-N 2-bromo-n-(diaminomethylidene)-4-(4-methylphenyl)-5-methylsulfonylbenzamide Chemical compound C1=CC(C)=CC=C1C1=CC(Br)=C(C(=O)N=C(N)N)C=C1S(C)(=O)=O OOYOJUWCHDVXOR-UHFFFAOYSA-N 0.000 description 1
- MOCAPAPTBJIECO-UHFFFAOYSA-N 2-bromo-n-(diaminomethylidene)-4-(4-methylphenyl)-5-sulfamoylbenzamide Chemical compound C1=CC(C)=CC=C1C1=CC(Br)=C(C(=O)N=C(N)N)C=C1S(N)(=O)=O MOCAPAPTBJIECO-UHFFFAOYSA-N 0.000 description 1
- QOXNIGXLROPWEM-UHFFFAOYSA-N 2-bromo-n-(diaminomethylidene)-5-phenylbenzamide Chemical compound C1=C(Br)C(C(=O)N=C(N)N)=CC(C=2C=CC=CC=2)=C1 QOXNIGXLROPWEM-UHFFFAOYSA-N 0.000 description 1
- YFBZDFORPCCUFL-UHFFFAOYSA-N 2-butan-2-yl-n-(diaminomethylidene)-4-(4-methylphenyl)-5-sulfamoylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(C(C)CC)=CC(C=2C=CC(C)=CC=2)=C1S(N)(=O)=O YFBZDFORPCCUFL-UHFFFAOYSA-N 0.000 description 1
- CXGYCLAVKIPOFG-UHFFFAOYSA-N 2-butan-2-yl-n-(diaminomethylidene)-4-phenyl-5-sulfamoylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(C(C)CC)=CC(C=2C=CC=CC=2)=C1S(N)(=O)=O CXGYCLAVKIPOFG-UHFFFAOYSA-N 0.000 description 1
- MCAFMNRQTKUHFM-UHFFFAOYSA-N 2-butan-2-yl-n-(diaminomethylidene)-5-methylsulfonyl-4-phenylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(C(C)CC)=CC(C=2C=CC=CC=2)=C1S(C)(=O)=O MCAFMNRQTKUHFM-UHFFFAOYSA-N 0.000 description 1
- WISKKSIALMOWHL-UHFFFAOYSA-N 2-butyl-n-(diaminomethylidene)-4-(4-methylphenyl)-5-sulfamoylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(CCCC)=CC(C=2C=CC(C)=CC=2)=C1S(N)(=O)=O WISKKSIALMOWHL-UHFFFAOYSA-N 0.000 description 1
- PZFXKNHZGOQLAH-UHFFFAOYSA-N 2-butyl-n-(diaminomethylidene)-4-phenyl-5-sulfamoylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(CCCC)=CC(C=2C=CC=CC=2)=C1S(N)(=O)=O PZFXKNHZGOQLAH-UHFFFAOYSA-N 0.000 description 1
- UBYMHLDYYBPFTB-UHFFFAOYSA-N 2-chloro-n-(diaminomethylidene)-4-(4-methylphenyl)-5-methylsulfonylbenzamide Chemical compound C1=CC(C)=CC=C1C1=CC(Cl)=C(C(=O)N=C(N)N)C=C1S(C)(=O)=O UBYMHLDYYBPFTB-UHFFFAOYSA-N 0.000 description 1
- BXOMXJPDASJWLH-UHFFFAOYSA-N 2-chloro-n-(diaminomethylidene)-4-(4-methylphenyl)-5-sulfamoylbenzamide Chemical compound C1=CC(C)=CC=C1C1=CC(Cl)=C(C(=O)N=C(N)N)C=C1S(N)(=O)=O BXOMXJPDASJWLH-UHFFFAOYSA-N 0.000 description 1
- XVBUIBSHULHRKL-UHFFFAOYSA-N 2-cyano-3-methylsulfonyl-4-phenylbenzoic acid Chemical compound C1=CC(C(O)=O)=C(C#N)C(S(=O)(=O)C)=C1C1=CC=CC=C1 XVBUIBSHULHRKL-UHFFFAOYSA-N 0.000 description 1
- UWDBNGVTSCAYLS-UHFFFAOYSA-N 2-cyano-4-phenyl-3-sulfamoylbenzoic acid Chemical compound C1=CC(C(O)=O)=C(C#N)C(S(=O)(=O)N)=C1C1=CC=CC=C1 UWDBNGVTSCAYLS-UHFFFAOYSA-N 0.000 description 1
- JTFKACVSDIFCPQ-UHFFFAOYSA-N 2-cyano-n-(diaminomethylidene)-3-methylsulfonyl-4-phenylbenzamide Chemical compound C1=CC(C(=O)N=C(N)N)=C(C#N)C(S(=O)(=O)C)=C1C1=CC=CC=C1 JTFKACVSDIFCPQ-UHFFFAOYSA-N 0.000 description 1
- GGCRHTVFMGQBTH-UHFFFAOYSA-N 2-cyano-n-(diaminomethylidene)-4-(4-methylphenyl)-5-methylsulfonylbenzamide Chemical compound C1=CC(C)=CC=C1C1=CC(C#N)=C(C(=O)N=C(N)N)C=C1S(C)(=O)=O GGCRHTVFMGQBTH-UHFFFAOYSA-N 0.000 description 1
- MFPGSXAELTZGLY-UHFFFAOYSA-N 2-cyano-n-(diaminomethylidene)-4-(4-methylphenyl)-5-sulfamoylbenzamide Chemical compound C1=CC(C)=CC=C1C1=CC(C#N)=C(C(=O)N=C(N)N)C=C1S(N)(=O)=O MFPGSXAELTZGLY-UHFFFAOYSA-N 0.000 description 1
- CCQQWFXXUVVBJU-UHFFFAOYSA-N 2-cyano-n-(diaminomethylidene)-4-phenyl-3-sulfamoylbenzamide Chemical compound NS(=O)(=O)C1=C(C#N)C(C(=O)N=C(N)N)=CC=C1C1=CC=CC=C1 CCQQWFXXUVVBJU-UHFFFAOYSA-N 0.000 description 1
- AAUPIIAOOZCSDG-UHFFFAOYSA-N 2-ethyl-4-phenyl-3-sulfamoylbenzoic acid Chemical compound CCC1=C(C(O)=O)C=CC(C=2C=CC=CC=2)=C1S(N)(=O)=O AAUPIIAOOZCSDG-UHFFFAOYSA-N 0.000 description 1
- SFQZCQDSVPIPSK-UHFFFAOYSA-N 2-fluoro-3-methylsulfonyl-4-phenylbenzoic acid Chemical compound CS(=O)(=O)C1=C(F)C(C(O)=O)=CC=C1C1=CC=CC=C1 SFQZCQDSVPIPSK-UHFFFAOYSA-N 0.000 description 1
- IBSFTULQFVSJKD-UHFFFAOYSA-N 2-fluoro-4-phenyl-3-sulfamoylbenzoic acid Chemical compound NS(=O)(=O)C1=C(F)C(C(O)=O)=CC=C1C1=CC=CC=C1 IBSFTULQFVSJKD-UHFFFAOYSA-N 0.000 description 1
- GAKIJEPUVBHWCK-UHFFFAOYSA-N 2-methoxy-2-(3,4,5-trimethoxyphenyl)ethanamine Chemical compound COC(CN)C1=CC(OC)=C(OC)C(OC)=C1 GAKIJEPUVBHWCK-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- GJOSXFZWYQHBGA-UHFFFAOYSA-N 4-(3-bromophenyl)-n-(diaminomethylidene)-2-methyl-5-methylsulfonylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(C)=CC(C=2C=C(Br)C=CC=2)=C1S(C)(=O)=O GJOSXFZWYQHBGA-UHFFFAOYSA-N 0.000 description 1
- GDLXHPJSCXFBSI-UHFFFAOYSA-N 4-(3-chlorophenyl)-2-methyl-3-methylsulfonylbenzoic acid Chemical compound CC1=C(C(O)=O)C=CC(C=2C=C(Cl)C=CC=2)=C1S(C)(=O)=O GDLXHPJSCXFBSI-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- UFLDNTRXSFBXED-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-ethynyl-3-methylsulfonylbenzoic acid Chemical compound C1=CC(C(O)=O)=C(C#C)C(S(=O)(=O)C)=C1C1=CC=C(Cl)C=C1 UFLDNTRXSFBXED-UHFFFAOYSA-N 0.000 description 1
- CXTPINURTVGWFM-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-ethynyl-3-sulfamoylbenzoic acid Chemical compound C1=CC(C(O)=O)=C(C#C)C(S(=O)(=O)N)=C1C1=CC=C(Cl)C=C1 CXTPINURTVGWFM-UHFFFAOYSA-N 0.000 description 1
- LUALUVDODQKXFD-UHFFFAOYSA-N 4-(4-methoxyphenyl)-2-nitro-3-sulfamoylbenzoic acid Chemical compound C1=CC(OC)=CC=C1C1=CC=C(C(O)=O)C([N+]([O-])=O)=C1S(N)(=O)=O LUALUVDODQKXFD-UHFFFAOYSA-N 0.000 description 1
- ALYIHDZFASIIDB-UHFFFAOYSA-N 4-bromo-2-methyl-5-methylsulfonylbenzoyl chloride Chemical compound CC1=CC(Br)=C(S(C)(=O)=O)C=C1C(Cl)=O ALYIHDZFASIIDB-UHFFFAOYSA-N 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- LBUNNMJLXWQQBY-UHFFFAOYSA-N 4-fluorophenylboronic acid Chemical compound OB(O)C1=CC=C(F)C=C1 LBUNNMJLXWQQBY-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- JXWZQNWDOHNEFL-UHFFFAOYSA-N C1=CC=C(C=C1)C2=CC(=C(C=C2)C(=O)N=C(N)N)S(=O)(=O)NF Chemical compound C1=CC=C(C=C1)C2=CC(=C(C=C2)C(=O)N=C(N)N)S(=O)(=O)NF JXWZQNWDOHNEFL-UHFFFAOYSA-N 0.000 description 1
- JYPPPKANMYAYAI-UHFFFAOYSA-N CC1=CC=C(C=C1)C2=C(C(=C(C=C2)C(=O)N=C(N)N)C)S(=O)(=O)C Chemical compound CC1=CC=C(C=C1)C2=C(C(=C(C=C2)C(=O)N=C(N)N)C)S(=O)(=O)C JYPPPKANMYAYAI-UHFFFAOYSA-N 0.000 description 1
- XWKSNCXGDPFWEK-UHFFFAOYSA-N CC1=CC=C(C=C1)C2=C(C=C(C(=C2)C)C(=O)NC(N)N)S(=O)(=O)C Chemical compound CC1=CC=C(C=C1)C2=C(C=C(C(=C2)C)C(=O)NC(N)N)S(=O)(=O)C XWKSNCXGDPFWEK-UHFFFAOYSA-N 0.000 description 1
- DWOVNQQHASTANO-UHFFFAOYSA-N CCC(C(S(N)(=O)=O)=C(C=C1)C2=CC=CC=C2)=C1C(N=C(N)N)=O.NC(N)=N.Cl Chemical compound CCC(C(S(N)(=O)=O)=C(C=C1)C2=CC=CC=C2)=C1C(N=C(N)N)=O.NC(N)=N.Cl DWOVNQQHASTANO-UHFFFAOYSA-N 0.000 description 1
- JHVXBCYVEYXLGK-UHFFFAOYSA-N CCCC1=C(C=CC(C1)(C2=CC=CC=C2)S(=O)(=O)C)C(=O)N=C(N)N Chemical compound CCCC1=C(C=CC(C1)(C2=CC=CC=C2)S(=O)(=O)C)C(=O)N=C(N)N JHVXBCYVEYXLGK-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- XSDQTOBWRPYKKA-UHFFFAOYSA-N amiloride Chemical compound NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N XSDQTOBWRPYKKA-UHFFFAOYSA-N 0.000 description 1
- 229960002576 amiloride Drugs 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003435 aroyl group Chemical group 0.000 description 1
- 230000002763 arrhythmic effect Effects 0.000 description 1
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 1
- 150000001543 aryl boronic acids Chemical class 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 150000003938 benzyl alcohols Chemical class 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000007248 cellular mechanism Effects 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 238000002635 electroconvulsive therapy Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- VZFJJCIGSJWRON-UHFFFAOYSA-N ethyl 2-methyl-5-phenylbenzoate Chemical compound CC1=C(C(=O)OCC)C=C(C=C1)C1=CC=CC=C1 VZFJJCIGSJWRON-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-M methanesulfonate group Chemical class CS(=O)(=O)[O-] AFVFQIVMOAPDHO-UHFFFAOYSA-M 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- BTLGOFBDMLTBMQ-UHFFFAOYSA-N methyl 2-(fluoromethyl)-4-(4-methylphenyl)-5-methylsulfonylbenzoate Chemical compound C1=C(CF)C(C(=O)OC)=CC(S(C)(=O)=O)=C1C1=CC=C(C)C=C1 BTLGOFBDMLTBMQ-UHFFFAOYSA-N 0.000 description 1
- NSUKKEFFKWSRKB-UHFFFAOYSA-N methyl 2-(fluoromethyl)-4-(4-methylphenyl)-5-sulfamoylbenzoate Chemical compound C1=C(CF)C(C(=O)OC)=CC(S(N)(=O)=O)=C1C1=CC=C(C)C=C1 NSUKKEFFKWSRKB-UHFFFAOYSA-N 0.000 description 1
- DONXXFXEOVKTQP-UHFFFAOYSA-N methyl 2-bromo-4-(4-methylphenyl)-5-methylsulfonylbenzoate Chemical compound C1=C(Br)C(C(=O)OC)=CC(S(C)(=O)=O)=C1C1=CC=C(C)C=C1 DONXXFXEOVKTQP-UHFFFAOYSA-N 0.000 description 1
- HVAYJHQMCBLZDY-UHFFFAOYSA-N methyl 2-bromo-4-(4-methylphenyl)-5-sulfamoylbenzoate Chemical compound C1=C(Br)C(C(=O)OC)=CC(S(N)(=O)=O)=C1C1=CC=C(C)C=C1 HVAYJHQMCBLZDY-UHFFFAOYSA-N 0.000 description 1
- QWMDRGWXCJBLGY-UHFFFAOYSA-N methyl 2-bromo-5-phenylbenzoate Chemical compound C1=C(Br)C(C(=O)OC)=CC(C=2C=CC=CC=2)=C1 QWMDRGWXCJBLGY-UHFFFAOYSA-N 0.000 description 1
- UJZOWWGDVMUHLN-UHFFFAOYSA-N methyl 2-butan-2-yl-4-(4-methylphenyl)-5-methylsulfonylbenzoate Chemical compound C1=C(C(=O)OC)C(C(C)CC)=CC(C=2C=CC(C)=CC=2)=C1S(C)(=O)=O UJZOWWGDVMUHLN-UHFFFAOYSA-N 0.000 description 1
- HSXGUCYFJKJAEJ-UHFFFAOYSA-N methyl 2-butan-2-yl-4-(4-methylphenyl)-5-sulfamoylbenzoate Chemical compound C1=C(C(=O)OC)C(C(C)CC)=CC(C=2C=CC(C)=CC=2)=C1S(N)(=O)=O HSXGUCYFJKJAEJ-UHFFFAOYSA-N 0.000 description 1
- UOQLOBLJYIVPTD-UHFFFAOYSA-N methyl 2-butan-2-yl-4-phenyl-5-sulfamoylbenzoate Chemical compound C1=C(C(=O)OC)C(C(C)CC)=CC(C=2C=CC=CC=2)=C1S(N)(=O)=O UOQLOBLJYIVPTD-UHFFFAOYSA-N 0.000 description 1
- KMDNOIYYCPGLMP-UHFFFAOYSA-N methyl 2-butan-2-yl-5-methylsulfonyl-4-phenylbenzoate Chemical compound C1=C(C(=O)OC)C(C(C)CC)=CC(C=2C=CC=CC=2)=C1S(C)(=O)=O KMDNOIYYCPGLMP-UHFFFAOYSA-N 0.000 description 1
- ZQJUWPPVFQGSFY-UHFFFAOYSA-N methyl 2-butyl-4-(4-methylphenyl)-5-methylsulfonylbenzoate Chemical compound C1=C(C(=O)OC)C(CCCC)=CC(C=2C=CC(C)=CC=2)=C1S(C)(=O)=O ZQJUWPPVFQGSFY-UHFFFAOYSA-N 0.000 description 1
- ATYZNLDDJQAWBS-UHFFFAOYSA-N methyl 2-butyl-4-phenyl-5-sulfamoylbenzoate Chemical compound C1=C(C(=O)OC)C(CCCC)=CC(C=2C=CC=CC=2)=C1S(N)(=O)=O ATYZNLDDJQAWBS-UHFFFAOYSA-N 0.000 description 1
- ZAMCIXGCRQEFLA-UHFFFAOYSA-N methyl 2-butyl-5-methylsulfonyl-4-phenylbenzoate Chemical compound C1=C(C(=O)OC)C(CCCC)=CC(C=2C=CC=CC=2)=C1S(C)(=O)=O ZAMCIXGCRQEFLA-UHFFFAOYSA-N 0.000 description 1
- VBTACEIKQNWCLK-UHFFFAOYSA-N methyl 2-chloro-4-(4-methylphenyl)-5-methylsulfonylbenzoate Chemical compound C1=C(Cl)C(C(=O)OC)=CC(S(C)(=O)=O)=C1C1=CC=C(C)C=C1 VBTACEIKQNWCLK-UHFFFAOYSA-N 0.000 description 1
- YIRCUHFMVREMAJ-UHFFFAOYSA-N methyl 2-chloro-4-(4-methylphenyl)-5-sulfamoylbenzoate Chemical compound C1=C(Cl)C(C(=O)OC)=CC(S(N)(=O)=O)=C1C1=CC=C(C)C=C1 YIRCUHFMVREMAJ-UHFFFAOYSA-N 0.000 description 1
- HBXMCSRFJJBVFP-UHFFFAOYSA-N methyl 2-cyano-4-(4-methylphenyl)-5-methylsulfonylbenzoate Chemical compound C1=C(C#N)C(C(=O)OC)=CC(S(C)(=O)=O)=C1C1=CC=C(C)C=C1 HBXMCSRFJJBVFP-UHFFFAOYSA-N 0.000 description 1
- JZGLVALGLXGYGG-UHFFFAOYSA-N methyl 2-cyano-4-(4-methylphenyl)-5-sulfamoylbenzoate Chemical compound C1=C(C#N)C(C(=O)OC)=CC(S(N)(=O)=O)=C1C1=CC=C(C)C=C1 JZGLVALGLXGYGG-UHFFFAOYSA-N 0.000 description 1
- VVKNKGSDVOGZAI-UHFFFAOYSA-N methyl 2-ethyl-4-(3-methylphenyl)-5-methylsulfonylbenzoate Chemical compound C1=C(C(=O)OC)C(CC)=CC(C=2C=C(C)C=CC=2)=C1S(C)(=O)=O VVKNKGSDVOGZAI-UHFFFAOYSA-N 0.000 description 1
- DBQZUISJPYCGIN-UHFFFAOYSA-N methyl 2-ethyl-4-(4-methylphenyl)-5-methylsulfonylbenzoate Chemical compound C1=C(C(=O)OC)C(CC)=CC(C=2C=CC(C)=CC=2)=C1S(C)(=O)=O DBQZUISJPYCGIN-UHFFFAOYSA-N 0.000 description 1
- VYSWYPXZHKHBHO-UHFFFAOYSA-N methyl 2-ethyl-4-phenyl-5-sulfamoylbenzoate Chemical compound C1=C(C(=O)OC)C(CC)=CC(C=2C=CC=CC=2)=C1S(N)(=O)=O VYSWYPXZHKHBHO-UHFFFAOYSA-N 0.000 description 1
- QHMIOHYJNJRUTL-UHFFFAOYSA-N methyl 2-ethyl-5-methylsulfonyl-4-phenylbenzoate Chemical compound C1=C(C(=O)OC)C(CC)=CC(C=2C=CC=CC=2)=C1S(C)(=O)=O QHMIOHYJNJRUTL-UHFFFAOYSA-N 0.000 description 1
- HRYIKZFEAMWMTE-UHFFFAOYSA-N methyl 2-ethynyl-4-(4-methylphenyl)-5-methylsulfonylbenzoate Chemical compound C1=C(C#C)C(C(=O)OC)=CC(S(C)(=O)=O)=C1C1=CC=C(C)C=C1 HRYIKZFEAMWMTE-UHFFFAOYSA-N 0.000 description 1
- KRWSNAQEKYWGIS-UHFFFAOYSA-N methyl 2-ethynyl-4-(4-methylphenyl)-5-sulfamoylbenzoate Chemical compound C1=C(C#C)C(C(=O)OC)=CC(S(N)(=O)=O)=C1C1=CC=C(C)C=C1 KRWSNAQEKYWGIS-UHFFFAOYSA-N 0.000 description 1
- JADCRNQRAUBJNS-UHFFFAOYSA-N methyl 2-methoxy-4-(4-methylphenyl)-5-methylsulfonylbenzoate Chemical compound C1=C(OC)C(C(=O)OC)=CC(S(C)(=O)=O)=C1C1=CC=C(C)C=C1 JADCRNQRAUBJNS-UHFFFAOYSA-N 0.000 description 1
- GDRCVFWAMNQRBD-UHFFFAOYSA-N methyl 2-methoxy-4-(4-methylphenyl)-5-sulfamoylbenzoate Chemical compound C1=C(OC)C(C(=O)OC)=CC(S(N)(=O)=O)=C1C1=CC=C(C)C=C1 GDRCVFWAMNQRBD-UHFFFAOYSA-N 0.000 description 1
- YUHXQFYLACJQDW-UHFFFAOYSA-N methyl 2-methyl-4-(4-methylphenyl)-5-sulfamoylbenzoate Chemical compound C1=C(C)C(C(=O)OC)=CC(S(N)(=O)=O)=C1C1=CC=C(C)C=C1 YUHXQFYLACJQDW-UHFFFAOYSA-N 0.000 description 1
- QOXIMPAZTRWJFG-UHFFFAOYSA-N methyl 4-(4-methylphenyl)-2-(1,1,2,2,2-pentafluoroethyl)-5-sulfamoylbenzoate Chemical compound C1=C(C(F)(F)C(F)(F)F)C(C(=O)OC)=CC(S(N)(=O)=O)=C1C1=CC=C(C)C=C1 QOXIMPAZTRWJFG-UHFFFAOYSA-N 0.000 description 1
- LFFWRJBKAPHKQU-UHFFFAOYSA-N methyl 4-(4-methylphenyl)-2-nitro-5-sulfamoylbenzoate Chemical compound C1=C([N+]([O-])=O)C(C(=O)OC)=CC(S(N)(=O)=O)=C1C1=CC=C(C)C=C1 LFFWRJBKAPHKQU-UHFFFAOYSA-N 0.000 description 1
- LETFZJYZMUJTGA-UHFFFAOYSA-N methyl 4-(4-methylphenyl)-2-propan-2-yl-5-sulfamoylbenzoate Chemical compound C1=C(C(C)C)C(C(=O)OC)=CC(S(N)(=O)=O)=C1C1=CC=C(C)C=C1 LETFZJYZMUJTGA-UHFFFAOYSA-N 0.000 description 1
- XWFMPAWPNHFGNJ-UHFFFAOYSA-N methyl 4-(4-methylphenyl)-2-propyl-5-sulfamoylbenzoate Chemical compound C1=C(C(=O)OC)C(CCC)=CC(C=2C=CC(C)=CC=2)=C1S(N)(=O)=O XWFMPAWPNHFGNJ-UHFFFAOYSA-N 0.000 description 1
- FMEHXBWJUDZMGR-UHFFFAOYSA-N methyl 4-(4-methylphenyl)-5-methylsulfonyl-2-(1,1,2,2,2-pentafluoroethyl)benzoate Chemical compound C1=C(C(F)(F)C(F)(F)F)C(C(=O)OC)=CC(S(C)(=O)=O)=C1C1=CC=C(C)C=C1 FMEHXBWJUDZMGR-UHFFFAOYSA-N 0.000 description 1
- WKEFKWRDGPOUDR-UHFFFAOYSA-N methyl 4-(4-methylphenyl)-5-methylsulfonyl-2-(trifluoromethyl)benzoate Chemical compound C1=C(C(F)(F)F)C(C(=O)OC)=CC(S(C)(=O)=O)=C1C1=CC=C(C)C=C1 WKEFKWRDGPOUDR-UHFFFAOYSA-N 0.000 description 1
- LBILBUVLXJVOGW-UHFFFAOYSA-N methyl 4-(4-methylphenyl)-5-methylsulfonyl-2-nitrobenzoate Chemical compound C1=C([N+]([O-])=O)C(C(=O)OC)=CC(S(C)(=O)=O)=C1C1=CC=C(C)C=C1 LBILBUVLXJVOGW-UHFFFAOYSA-N 0.000 description 1
- GIDNHHREXBCESC-UHFFFAOYSA-N methyl 4-(4-methylphenyl)-5-methylsulfonyl-2-propan-2-ylbenzoate Chemical compound C1=C(C(C)C)C(C(=O)OC)=CC(S(C)(=O)=O)=C1C1=CC=C(C)C=C1 GIDNHHREXBCESC-UHFFFAOYSA-N 0.000 description 1
- HPZSEDOJOWMNQD-UHFFFAOYSA-N methyl 4-(4-methylphenyl)-5-methylsulfonyl-2-propylbenzoate Chemical compound C1=C(C(=O)OC)C(CCC)=CC(C=2C=CC(C)=CC=2)=C1S(C)(=O)=O HPZSEDOJOWMNQD-UHFFFAOYSA-N 0.000 description 1
- MQKVQRPDVHOLGN-UHFFFAOYSA-N methyl 4-(4-methylphenyl)-5-sulfamoyl-2-(trifluoromethyl)benzoate Chemical compound C1=C(C(F)(F)F)C(C(=O)OC)=CC(S(N)(=O)=O)=C1C1=CC=C(C)C=C1 MQKVQRPDVHOLGN-UHFFFAOYSA-N 0.000 description 1
- XSXXWEUWVMYGPQ-UHFFFAOYSA-N methyl 4-bromo-2-ethyl-3-methylsulfonylbenzoate Chemical compound CCC1=C(C(=O)OC)C=CC(Br)=C1S(C)(=O)=O XSXXWEUWVMYGPQ-UHFFFAOYSA-N 0.000 description 1
- SVMSKHHMAKYMAH-UHFFFAOYSA-N methyl 4-bromo-2-ethyl-3-sulfamoylbenzoate Chemical compound CCC1=C(C(=O)OC)C=CC(Br)=C1S(N)(=O)=O SVMSKHHMAKYMAH-UHFFFAOYSA-N 0.000 description 1
- QXEUTIBQTXUECQ-UHFFFAOYSA-N methyl 4-bromo-2-methyl-5-methylsulfonylbenzoate Chemical compound COC(=O)C1=CC(S(C)(=O)=O)=C(Br)C=C1C QXEUTIBQTXUECQ-UHFFFAOYSA-N 0.000 description 1
- XGPLNHHOOREOPD-UHFFFAOYSA-N methyl 4-bromo-2-methyl-5-sulfamoylbenzoate Chemical compound COC(=O)C1=CC(S(N)(=O)=O)=C(Br)C=C1C XGPLNHHOOREOPD-UHFFFAOYSA-N 0.000 description 1
- MKMCGEMSDDFQQN-UHFFFAOYSA-N methyl 4-phenyl-2-propan-2-yl-5-sulfamoylbenzoate Chemical compound C1=C(C(C)C)C(C(=O)OC)=CC(S(N)(=O)=O)=C1C1=CC=CC=C1 MKMCGEMSDDFQQN-UHFFFAOYSA-N 0.000 description 1
- CZFDVBLIOMZAML-UHFFFAOYSA-N methyl 4-phenyl-2-propyl-5-sulfamoylbenzoate Chemical compound C1=C(C(=O)OC)C(CCC)=CC(C=2C=CC=CC=2)=C1S(N)(=O)=O CZFDVBLIOMZAML-UHFFFAOYSA-N 0.000 description 1
- XZJOLCJDAXCZIB-UHFFFAOYSA-N methyl 5-methylsulfonyl-4-phenyl-2-propan-2-ylbenzoate Chemical compound C1=C(C(C)C)C(C(=O)OC)=CC(S(C)(=O)=O)=C1C1=CC=CC=C1 XZJOLCJDAXCZIB-UHFFFAOYSA-N 0.000 description 1
- KCBAKXCVTVCHDT-UHFFFAOYSA-N methyl 5-methylsulfonyl-4-phenyl-2-propylbenzoate Chemical compound C1=C(C(=O)OC)C(CCC)=CC(C=2C=CC=CC=2)=C1S(C)(=O)=O KCBAKXCVTVCHDT-UHFFFAOYSA-N 0.000 description 1
- CJGRKNPEUUYZNZ-UHFFFAOYSA-N methyl 5-phenyl-2-(trifluoromethyl)benzoate Chemical compound FC(C1=C(C(=O)OC)C=C(C=C1)C1=CC=CC=C1)(F)F CJGRKNPEUUYZNZ-UHFFFAOYSA-N 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- NWIFAODIIGDPKK-UHFFFAOYSA-N n-(diaminomethylidene)-2-(difluoromethyl)-3-methylsulfonyl-4-phenylbenzamide Chemical compound C1=CC(C(=O)N=C(N)N)=C(C(F)F)C(S(=O)(=O)C)=C1C1=CC=CC=C1 NWIFAODIIGDPKK-UHFFFAOYSA-N 0.000 description 1
- MQZIXEKMVBETEP-UHFFFAOYSA-N n-(diaminomethylidene)-2-(difluoromethyl)-4-phenyl-3-sulfamoylbenzamide Chemical compound NS(=O)(=O)C1=C(C(F)F)C(C(=O)N=C(N)N)=CC=C1C1=CC=CC=C1 MQZIXEKMVBETEP-UHFFFAOYSA-N 0.000 description 1
- YGJFTHLXJNCZCS-UHFFFAOYSA-N n-(diaminomethylidene)-2-ethyl-4-(4-methylphenyl)-5-sulfamoylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(CC)=CC(C=2C=CC(C)=CC=2)=C1S(N)(=O)=O YGJFTHLXJNCZCS-UHFFFAOYSA-N 0.000 description 1
- MIFJSZZMISAKRO-UHFFFAOYSA-N n-(diaminomethylidene)-2-ethyl-4-phenyl-5-sulfamoylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(CC)=CC(C=2C=CC=CC=2)=C1S(N)(=O)=O MIFJSZZMISAKRO-UHFFFAOYSA-N 0.000 description 1
- VPYVIEAMLCHWOD-UHFFFAOYSA-N n-(diaminomethylidene)-2-ethynyl-4-(4-methylphenyl)-5-methylsulfonylbenzamide Chemical compound C1=CC(C)=CC=C1C1=CC(C#C)=C(C(=O)N=C(N)N)C=C1S(C)(=O)=O VPYVIEAMLCHWOD-UHFFFAOYSA-N 0.000 description 1
- MRHMCNNZUMRVHL-UHFFFAOYSA-N n-(diaminomethylidene)-2-ethynyl-4-(4-methylphenyl)-5-sulfamoylbenzamide Chemical compound C1=CC(C)=CC=C1C1=CC(C#C)=C(C(=O)N=C(N)N)C=C1S(N)(=O)=O MRHMCNNZUMRVHL-UHFFFAOYSA-N 0.000 description 1
- VDYXPKGLGJFFOI-UHFFFAOYSA-N n-(diaminomethylidene)-2-fluoro-3-methylsulfonyl-4-phenylbenzamide Chemical compound CS(=O)(=O)C1=C(F)C(C(=O)N=C(N)N)=CC=C1C1=CC=CC=C1 VDYXPKGLGJFFOI-UHFFFAOYSA-N 0.000 description 1
- RRNRKAINBHCPML-UHFFFAOYSA-N n-(diaminomethylidene)-2-methoxy-4-(4-methylphenyl)-5-sulfamoylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(OC)=CC(C=2C=CC(C)=CC=2)=C1S(N)(=O)=O RRNRKAINBHCPML-UHFFFAOYSA-N 0.000 description 1
- MWDRMUUOWGFQPF-UHFFFAOYSA-N n-(diaminomethylidene)-2-methyl-4-(3-methylphenyl)-5-methylsulfonylbenzamide Chemical compound CC1=CC=CC(C=2C(=CC(=C(C)C=2)C(=O)N=C(N)N)S(C)(=O)=O)=C1 MWDRMUUOWGFQPF-UHFFFAOYSA-N 0.000 description 1
- AWDLZBRWTJYMIQ-UHFFFAOYSA-N n-(diaminomethylidene)-2-methyl-4-(4-methylphenyl)-5-sulfamoylbenzamide Chemical compound C1=CC(C)=CC=C1C1=CC(C)=C(C(=O)N=C(N)N)C=C1S(N)(=O)=O AWDLZBRWTJYMIQ-UHFFFAOYSA-N 0.000 description 1
- KLCIGVULBVLLJU-UHFFFAOYSA-N n-(diaminomethylidene)-4-(4-methylphenyl)-2-(1,1,2,2,2-pentafluoroethyl)-5-sulfamoylbenzamide Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)C(F)(F)F)=C(C(=O)N=C(N)N)C=C1S(N)(=O)=O KLCIGVULBVLLJU-UHFFFAOYSA-N 0.000 description 1
- XKIQFHGQOKFWPH-UHFFFAOYSA-N n-(diaminomethylidene)-4-(4-methylphenyl)-2-nitro-5-sulfamoylbenzamide Chemical compound C1=CC(C)=CC=C1C1=CC([N+]([O-])=O)=C(C(=O)N=C(N)N)C=C1S(N)(=O)=O XKIQFHGQOKFWPH-UHFFFAOYSA-N 0.000 description 1
- QNFDRKOVLWEEBD-UHFFFAOYSA-N n-(diaminomethylidene)-4-(4-methylphenyl)-2-propan-2-yl-5-sulfamoylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(C(C)C)=CC(C=2C=CC(C)=CC=2)=C1S(N)(=O)=O QNFDRKOVLWEEBD-UHFFFAOYSA-N 0.000 description 1
- FNMDYBIKPBVINF-UHFFFAOYSA-N n-(diaminomethylidene)-4-(4-methylphenyl)-2-propyl-5-sulfamoylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(CCC)=CC(C=2C=CC(C)=CC=2)=C1S(N)(=O)=O FNMDYBIKPBVINF-UHFFFAOYSA-N 0.000 description 1
- UWDZPORUAVTTTO-UHFFFAOYSA-N n-(diaminomethylidene)-4-(4-methylphenyl)-5-methylsulfonyl-2-(trifluoromethyl)benzamide Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=C(C(=O)N=C(N)N)C=C1S(C)(=O)=O UWDZPORUAVTTTO-UHFFFAOYSA-N 0.000 description 1
- JTKYFLPCNNXSSN-UHFFFAOYSA-N n-(diaminomethylidene)-4-(4-methylphenyl)-5-methylsulfonyl-2-propylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(CCC)=CC(C=2C=CC(C)=CC=2)=C1S(C)(=O)=O JTKYFLPCNNXSSN-UHFFFAOYSA-N 0.000 description 1
- HCTDDGLQPCVIKL-UHFFFAOYSA-N n-(diaminomethylidene)-4-phenyl-2-propan-2-yl-5-sulfamoylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(C(C)C)=CC(C=2C=CC=CC=2)=C1S(N)(=O)=O HCTDDGLQPCVIKL-UHFFFAOYSA-N 0.000 description 1
- PHCVTMANMMUCIW-UHFFFAOYSA-N n-(diaminomethylidene)-5-methylsulfonyl-4-phenyl-2-propylbenzamide Chemical compound C1=C(C(=O)N=C(N)N)C(CCC)=CC(C=2C=CC=CC=2)=C1S(C)(=O)=O PHCVTMANMMUCIW-UHFFFAOYSA-N 0.000 description 1
- CEZLIQQDYPHMQB-UHFFFAOYSA-N n-(diaminomethylidene)-5-phenyl-2-(trifluoromethyl)benzamide Chemical compound C1=C(C(F)(F)F)C(C(=O)N=C(N)N)=CC(C=2C=CC=CC=2)=C1 CEZLIQQDYPHMQB-UHFFFAOYSA-N 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 150000002828 nitro derivatives Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 238000007339 nucleophilic aromatic substitution reaction Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000003232 p-nitrobenzoyl group Chemical group [N+](=O)([O-])C1=CC=C(C(=O)*)C=C1 0.000 description 1
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000894 saliuretic effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000003107 substituted aryl group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical compound NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000005425 toluyl group Chemical group 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C317/50—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Electroluminescent Light Sources (AREA)
- Photoreceptors In Electrophotography (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4430213A DE4430213A1 (de) | 1994-08-28 | 1994-08-28 | Arylbenzoylguanidine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK105395A3 SK105395A3 (en) | 1996-03-06 |
| SK281135B6 true SK281135B6 (sk) | 2000-12-11 |
Family
ID=6526570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1053-95A SK281135B6 (sk) | 1994-08-28 | 1995-08-25 | Derivát arylbenzoylguanidínu, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5807896A (fr) |
| EP (1) | EP0699660B1 (fr) |
| JP (1) | JPH0859598A (fr) |
| KR (1) | KR960007540A (fr) |
| CN (1) | CN1055919C (fr) |
| AT (1) | ATE172716T1 (fr) |
| AU (1) | AU704630B2 (fr) |
| BR (1) | BR9503810A (fr) |
| CA (1) | CA2156960A1 (fr) |
| CZ (1) | CZ289058B6 (fr) |
| DE (2) | DE4430213A1 (fr) |
| ES (1) | ES2125537T3 (fr) |
| HU (1) | HU216833B (fr) |
| NO (1) | NO305242B1 (fr) |
| PL (1) | PL180872B1 (fr) |
| RU (1) | RU2153490C2 (fr) |
| SK (1) | SK281135B6 (fr) |
| TW (1) | TW386988B (fr) |
| UA (1) | UA44237C2 (fr) |
| ZA (1) | ZA957163B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4328352A1 (de) * | 1993-08-24 | 1995-03-02 | Hoechst Ag | Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| CA2195697A1 (fr) | 1996-02-02 | 1997-08-03 | Masahumi Kitano | Derives substitues de la guanidine, procede pour leur obtention et leurs utilisations pharmaceutiques |
| DE19608161A1 (de) * | 1996-03-04 | 1997-09-11 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19624178A1 (de) * | 1996-06-18 | 1998-01-08 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19833118C2 (de) * | 1998-07-23 | 2000-07-27 | Merck Patent Gmbh | Verfahren zur Herstellung von orthoalkylierten Benzoesäurederivaten |
| GB0225548D0 (en) * | 2002-11-01 | 2002-12-11 | Glaxo Group Ltd | Compounds |
| ATE440827T1 (de) * | 2002-12-04 | 2009-09-15 | Ore Pharmaceuticals Inc | Melanocortin-rezeptormodulatoren |
| GB0323585D0 (en) * | 2003-10-08 | 2003-11-12 | Glaxo Group Ltd | Compounds |
| GB0323584D0 (en) * | 2003-10-08 | 2003-11-12 | Glaxo Group Ltd | Compounds |
| GB0323581D0 (en) * | 2003-10-08 | 2003-11-12 | Glaxo Group Ltd | Novel compounds |
| GB0410121D0 (en) * | 2004-05-06 | 2004-06-09 | Glaxo Group Ltd | Compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3420874A (en) * | 1962-09-28 | 1969-01-07 | Standard Oil Co | Amine addition salts of nitro-carboxyalkali metal phenolates |
| EP0556673B1 (fr) * | 1992-02-15 | 1997-09-17 | Hoechst Aktiengesellschaft | Benzoylguanidines ortho-substitués, procédé pour leur préparation, leur utilisation comme medicament ou agent diagnostique, ainsi que médicament les contenant |
| CZ284456B6 (cs) * | 1992-02-15 | 1998-12-16 | Hoechst Aktiengesellschaft | Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje |
| ES2092729T3 (es) * | 1992-07-01 | 1996-12-01 | Hoechst Ag | Benzoilguanidinas 3,4,5-sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como medicamento que las contiene. |
| DK0603650T3 (da) * | 1992-12-16 | 1997-10-20 | Hoechst Ag | 3,5-Substituerede aminobenzoylguanidiner, fremgangsmåde til deres freemstilling, deres anvendelse som lægemiddel eller diagnostikum samt lægemiddel med indhold deraf. |
| EP0604852A1 (fr) * | 1992-12-28 | 1994-07-06 | Hoechst Aktiengesellschaft | 5-Sulfamoylbenzoylguanidines 2,4,N-substituées, comme agents antiarhythmiques, inhibiteurs de la prolifération des cellules, et inhibiteurs de l'écharge sodium-hydrogène |
| ATE157351T1 (de) * | 1993-02-20 | 1997-09-15 | Hoechst Ag | Substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament, als inhibitoren des zellulären na+/h+-austauschs oder als diagnostikum sowie sie enthaltendes medikament |
| DE4318756A1 (de) * | 1993-06-05 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1994
- 1994-08-28 DE DE4430213A patent/DE4430213A1/de not_active Withdrawn
-
1995
- 1995-07-21 TW TW084107589A patent/TW386988B/zh active
- 1995-08-21 AU AU30144/95A patent/AU704630B2/en not_active Ceased
- 1995-08-21 EP EP95113105A patent/EP0699660B1/fr not_active Expired - Lifetime
- 1995-08-21 DE DE59504053T patent/DE59504053D1/de not_active Expired - Fee Related
- 1995-08-21 ES ES95113105T patent/ES2125537T3/es not_active Expired - Lifetime
- 1995-08-21 AT AT95113105T patent/ATE172716T1/de not_active IP Right Cessation
- 1995-08-23 UA UA95083913A patent/UA44237C2/uk unknown
- 1995-08-25 CZ CZ19952182A patent/CZ289058B6/cs not_active IP Right Cessation
- 1995-08-25 RU RU95114440/04A patent/RU2153490C2/ru not_active IP Right Cessation
- 1995-08-25 CA CA002156960A patent/CA2156960A1/fr not_active Abandoned
- 1995-08-25 SK SK1053-95A patent/SK281135B6/sk unknown
- 1995-08-25 CN CN95116621A patent/CN1055919C/zh not_active Expired - Fee Related
- 1995-08-25 ZA ZA957163A patent/ZA957163B/xx unknown
- 1995-08-25 PL PL95310193A patent/PL180872B1/pl not_active IP Right Cessation
- 1995-08-25 US US08/519,182 patent/US5807896A/en not_active Expired - Fee Related
- 1995-08-25 BR BR9503810A patent/BR9503810A/pt not_active Application Discontinuation
- 1995-08-25 NO NO953351A patent/NO305242B1/no not_active IP Right Cessation
- 1995-08-28 HU HU9502516A patent/HU216833B/hu not_active IP Right Cessation
- 1995-08-28 JP JP7240499A patent/JPH0859598A/ja active Pending
- 1995-08-28 KR KR1019950026799A patent/KR960007540A/ko active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| ZA957163B (en) | 1996-04-17 |
| NO953351L (no) | 1996-02-29 |
| EP0699660B1 (fr) | 1998-10-28 |
| AU704630B2 (en) | 1999-04-29 |
| UA44237C2 (uk) | 2002-02-15 |
| JPH0859598A (ja) | 1996-03-05 |
| NO953351D0 (no) | 1995-08-25 |
| EP0699660A3 (fr) | 1996-03-20 |
| BR9503810A (pt) | 1996-04-16 |
| RU2153490C2 (ru) | 2000-07-27 |
| PL180872B1 (pl) | 2001-04-30 |
| ES2125537T3 (es) | 1999-03-01 |
| CZ218295A3 (en) | 1996-03-13 |
| ATE172716T1 (de) | 1998-11-15 |
| HUT72303A (en) | 1996-04-29 |
| PL310193A1 (en) | 1996-03-04 |
| CN1055919C (zh) | 2000-08-30 |
| KR960007540A (ko) | 1996-03-22 |
| US5807896A (en) | 1998-09-15 |
| DE4430213A1 (de) | 1996-02-29 |
| CZ289058B6 (cs) | 2001-10-17 |
| SK105395A3 (en) | 1996-03-06 |
| NO305242B1 (no) | 1999-04-26 |
| HU216833B (hu) | 1999-09-28 |
| TW386988B (en) | 2000-04-11 |
| CA2156960A1 (fr) | 1996-03-01 |
| AU3014495A (en) | 1996-03-14 |
| HU9502516D0 (en) | 1995-10-30 |
| CN1117962A (zh) | 1996-03-06 |
| EP0699660A2 (fr) | 1996-03-06 |
| DE59504053D1 (de) | 1998-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL179255B1 (pl) | N owe pochodne 4-aminopiperydylo-(1 )-benzoiloguanidyny, sposób ich wytwarzania oraz preparat farmaceutyczny PL PL PL PL PL PL PL | |
| CA2157146C (fr) | Heterocyclyl-benzolyguanidines | |
| AU703633B2 (en) | Ortho-substituted benzoic acid derivatives | |
| SK281135B6 (sk) | Derivát arylbenzoylguanidínu, spôsob jeho prípravy, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje | |
| KR100447111B1 (ko) | 술포닐벤조일구아니딘또는술피닐벤조일구아니딘유도체 | |
| AU701558B2 (en) | Alkylbenzoylguanidine derivatives | |
| SK281198B6 (sk) | Derivát 4-aminobenzoylguanidínu, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje | |
| US5700839A (en) | Alkyl-5-methylsulfonylbenzoylguanidine derivatives | |
| US5731351A (en) | Alkenyl-benzoylguanidine derivatives | |
| AU706843B2 (en) | 4-mercaptobenzoylguanidine derivatives |